Leadership Overview
Hypera Pharma has 5 executives leading key functions including strategy, finance, operations, marketing, and staff coordination.
Driven by innovation, Hypera Pharma is dedicated to advancing healthcare solutions and improving patient well-being through its extensive pharmaceutical offerings, solidifying its market leadership in Brazil.
Driven by innovation, Hypera Pharma is dedicated to advancing healthcare solutions and improving patient well-being through its extensive pharmaceutical offerings, solidifying its market leadership in Brazil.
Leadership Roles at Hypera Pharma
Andrija Ratkovic - Chief Executive Officer
Andrija Ratkovic, the Chief Executive Officer at Hypera Pharma, directs the company's overarching strategy and operational execution. This leadership role involves guiding all business units to achieve ambitious growth targets within the competitive pharmaceutical landscape. Ratkovic ensures alignment across departments, fostering a culture of innovation essential for developing and distributing vital healthcare products. Overseeing market expansion initiatives, Andrija Ratkovic drives the company's presence in key regions, adapting strategies to meet evolving healthcare needs. The Chief Executive Officer's responsibilities extend to stakeholder relations, ensuring robust communication with investors and regulatory bodies, thereby safeguarding the company's financial health and market reputation. This executive function is critical for maintaining Hypera Pharma's position as a leader in the Brazilian pharmaceutical sector.
Lívia Machado Borges - Chief Financial Officer
Lívia Machado Borges, the Chief Financial Officer at Hypera Pharma, directs all financial operations and fiscal strategy for the organization. This executive function encompasses financial planning, budgeting, risk management, and capital allocation to support the company's growth objectives. Borges ensures the integrity of financial reporting and compliance with all relevant regulations, safeguarding the company's assets and investor confidence. Overseeing investment strategies, Lívia Machado Borges identifies opportunities for financial optimization and sustainable revenue generation within the pharmaceutical sector. The Chief Financial Officer's leadership is crucial for maintaining Hypera Pharma's strong financial standing, enabling continued investment in research, development, and market expansion. Borges's expertise underpins the company's ability to navigate economic complexities and achieve long-term profitability.
Rafael Batista - Diretor Executivo De Operações - Chief Operating Officer
Rafael Batista, the Diretor Executivo De Operações - Chief Operating Officer at Hypera Pharma, manages the company's extensive operational infrastructure and supply chain logistics. This executive function is critical for ensuring the efficient production, distribution, and delivery of pharmaceutical products across Brazil and beyond. Batista oversees manufacturing processes, quality control, and inventory management, optimizing workflows to enhance productivity and reduce operational costs. Driving operational excellence, Rafael Batista implements best practices to maintain high standards of product quality and safety. The Chief Operating Officer's leadership ensures that Hypera Pharma can meet market demand reliably and effectively, supporting the company's mission to provide accessible healthcare solutions. Batista's focus on operational efficiency is fundamental to the company's ability to scale and maintain its competitive edge.
Thiago Rabello - Chief of Staff
Thiago Rabello, the Chief of Staff at Hypera Pharma, facilitates strategic initiatives and ensures seamless operational flow across the executive team. This position involves coordinating cross-functional projects, optimizing internal communication channels, and driving key organizational priorities. Rabello supports the Chief Executive Officer by managing critical workflows and preparing essential documentation for board meetings and strategic planning sessions. Overseeing special projects, Thiago Rabello enhances operational efficiency and supports the implementation of new business strategies. The Chief of Staff's role is pivotal in translating high-level objectives into actionable plans, ensuring that all departments work cohesively towards Hypera Pharma's mission of improving healthcare access. Rabello's efforts directly contribute to the company's agility and responsiveness in the dynamic pharmaceutical market.
Carla Araújo - Chief Marketing Officer, OTC Brands & Foods
Carla Araújo, the Chief Marketing Officer, OTC Brands & Foods at Hypera Pharma, spearheads the marketing strategies for the company's over-the-counter and food product lines. This role involves developing and executing comprehensive marketing campaigns designed to enhance brand visibility, drive consumer engagement, and increase market share. Araújo oversees product positioning, pricing strategies, and promotional activities, ensuring alignment with consumer needs and market trends in the healthcare and food sectors. Driving brand growth, Carla Araújo leads initiatives to expand the reach of Hypera Pharma's consumer-facing products. The Chief Marketing Officer's responsibilities include analyzing market data to identify new opportunities and optimizing marketing spend for maximum return on investment. Araújo's strategic direction is vital for strengthening Hypera Pharma's consumer brand portfolio and achieving sustained sales growth.
Explore Leadership Teams in Manufacturing
Bristol-Myers Squibb operates as a global biopharmaceutical organization dedicated to discovering, developing, and manufacturing prescription medications that address serious patient needs across multiple therapeutic domains. The company's scientific expertise spans oncology, cardiovascular disease, immunoscience, and virology, with particular depth in treating complex conditions including HIV and cancer. Through sustained investment in research and development, the organization has built a comprehensive medication portfolio that combines innovative cancer immunotherapies, anticoagulant therapies, and treatments for chronic viral infections. The company's operational footprint extends across major markets worldwide, enabling efficient distribution and patient access to its therapeutic solutions. Bristol-Myers Squibb pursues a collaborative approach to medical innovation, actively engaging in research partnerships and strategic alliances that accelerate the development of new treatment options. This commitment to external collaboration complements the organization's internal capabilities, creating a dynamic environment where scientific breakthroughs can translate into meaningful therapeutic advances. Bristol-Myers Squibb's medication portfolio reflects decades of pharmaceutical expertise and a strategic focus on disease areas where unmet medical needs remain significant.
Company Leadership BT
DG
KK
Zoetis discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. The company offers vaccines, medicated feed additives that offer medicines to livestock; and other pharmaceutical products, which comprise allergy and dermatology, pain and sedation, antiemetic, reproductive, and oncology products. It markets to veterinarians, livestock producers, and retail outlets, as well as third-party veterinary distributors through its sales representatives, and technical and veterinary operations specialists. The company is headquartered in Parsippany, New Jersey.
Company Leadership KK
MT
GT
PharmaLogic Holdings Corp. is a global contract development and manufacturing organization (CDMO) specializing in diagnostic and therapeutic radiopharmaceuticals. Through a network of radiopharmacies and manufacturing facilities across North America and Europe, it develops, manufactures, and distributes clinical and commercial radiopharmaceutical products to pharmaceutical partners and healthcare providers.
Company Leadership
GP
MD
HP
Genomma Lab Internacional is a leading provider of innovative health and personal care products aimed at enhancing health and well-being. The company offers a wide range of solutions for various health issues, including hydration, pain relief, and skincare. Its intended clients include individuals seeking effective and safe products to improve their quality of life. Genomma Lab is committed to sustainability and positively impacting communities while ensuring the satisfaction of its shareholders.
Company Leadership RA
GC
AG
MG
Frequently Asked Questions Regarding Hypera Pharma Top Executives and Leadership Team
